The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population.

ABSTRACT: Background: In the United States (US), colorectal cancer (CRC) is the second leading cause of cancer-related deaths. With the majority of the US population covered by employer-based health plans, employers can play a critical role in increasing CRC screening adherence, which may help avert CRC-related deaths. Therefore, it is important for self-insured employers to consider the impact of appropriate utilization of CRC screening options. Objective: To evaluate the impact of increasing multitarget stool DNA [mt-sDNA (Cologuard®)] use among CRC screeners from the perspective of a US self-insured employer. Methods:A 5-year Markov model was developed to quantify the budget impact of increasing mt-sDNA from 6% to 15% among average-risk screeners using colonoscopy, fecal immu

SUBMITTER: Hathway JM 

PROVIDER: S-EPMC8425769 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature